Inhibition of the ABL Kinase Activity Blocks the Proliferation of BCR/ABL+Leukemic Cells and Induces Apoptosis-Reference-Cited by-同舟云学术

Inhibition of the ABL Kinase Activity Blocks the Proliferation of BCR/ABL+Leukemic Cells and Induces Apoptosis

Published:1997-12 Issue:3 Volume:23 Page:380-394
ISSN:1079-9796
Container-title:Blood Cells, Molecules, and Diseases
language:en
Short-container-title:Blood Cells, Molecules, and Diseases

Author:

Gambacorti-Passerini Carlo,le Coutre Philipp,Mologni Luca,Fanelli Mirco,Bertazzoli Carla,Marchesi Edoardo,Di Nicola Massimo,Biondi Andrea,Corneo Gian Marco,Belotti Daniela,Pogliani Enrico,Lydon Nicholas B.

Publisher

Elsevier BV

Subject

Cell Biology,Hematology,Molecular Biology,Molecular Medicine

Reference29 articles.

1. Structural organization of the bcr gene and its role in the Ph1;Heisterkamp;Nature,1985

2. An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity;Konopa;Cell,1984

3. Induction of chronic myelogenous leukemia in mice by the P210BCR/ABL;Daley;Science,1990

4. Inhibition of proto oncogene expression by antisense oligo-deoxynucleotides: biological and therapeutic implications;Calabretta;Cancer Res,1991

5. Recognition of BCR-ABL positive leukemic blasts by human CD4+in vitro;Ten Bosch;Blood,1996

Cited by 274 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A thin-film molecularly imprinted polymer for the measurement of tyrosine kinase inhibitors in human plasma;Talanta Open;2023-12

2. Advancing Precision Medicine;Handbook of Cancer and Immunology;2023-11-08

3. Pyridine ring as an important scaffold in anticancer drugs;Recent Developments in the Synthesis and Applications of Pyridines;2023

4. Preclinical Cancer Models for the Evaluation of Immunotherapies: From Cell Lines to Animal Models;Handbook of Cancer and Immunology;2022-12-28

5. Does the pursuit of scientific excellence serve or hamper translational medical research: an historical perspective from hematological malignancies;Blood Cancer Journal;2022-10-07